208 related articles for article (PubMed ID: 32383745)
1. Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer.
McMahon KR; Rassekh SR; Schultz KR; Blydt-Hansen T; Cuvelier GDE; Mammen C; Pinsk M; Carleton BC; Tsuyuki RT; Ross CJD; Palijan A; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Boyko D; Zappitelli M;
JAMA Netw Open; 2020 May; 3(5):e203639. PubMed ID: 32383745
[TBL] [Abstract][Full Text] [Related]
2. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
McMahon KR; Lebel A; Rassekh SR; Schultz KR; Blydt-Hansen TD; Cuvelier GDE; Mammen C; Pinsk M; Carleton BC; Tsuyuki RT; Ross CJD; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Palijan A; Lee J; Boyko D; Zappitelli M;
Pediatr Nephrol; 2023 May; 38(5):1667-1685. PubMed ID: 36260162
[TBL] [Abstract][Full Text] [Related]
4. Frequency and Risk Factors of Acute Kidney Injury During Diabetic Ketoacidosis in Children and Association With Neurocognitive Outcomes.
Myers SR; Glaser NS; Trainor JL; Nigrovic LE; Garro A; Tzimenatos L; Quayle KS; Kwok MY; Rewers A; Stoner MJ; Schunk JE; McManemy JK; Brown KM; DePiero AD; Olsen CS; Casper TC; Ghetti S; Kuppermann N;
JAMA Netw Open; 2020 Dec; 3(12):e2025481. PubMed ID: 33275152
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study.
Moke DJ; Luo C; Millstein J; Knight KR; Rassekh SR; Brooks B; Ross CJD; Wright M; Mena V; Rushing T; Esbenshade AJ; Carleton BC; Orgel E
Lancet Child Adolesc Health; 2021 Apr; 5(4):274-283. PubMed ID: 33581749
[TBL] [Abstract][Full Text] [Related]
6. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury in Children With Type 1 Diabetes Hospitalized for Diabetic Ketoacidosis.
Hursh BE; Ronsley R; Islam N; Mammen C; Panagiotopoulos C
JAMA Pediatr; 2017 May; 171(5):e170020. PubMed ID: 28288246
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
[TBL] [Abstract][Full Text] [Related]
9. Association of Ibuprofen Prescription With Acute Kidney Injury Among Hospitalized Children in China.
Su L; Li Y; Xu R; Luo F; Gao Q; Chen R; Cao Y; Nie S; Xu X;
JAMA Netw Open; 2021 Mar; 4(3):e210775. PubMed ID: 33662136
[TBL] [Abstract][Full Text] [Related]
10. Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin.
Chui H; McMahon KR; Rassekh SR; Schultz KR; Blydt-Hansen TD; Mammen C; Pinsk M; Cuvelier GDE; Carleton BC; Tsuyuki RT; Ross CJD; Devarajan P; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Cockovski V; Palijan A; Zappitelli M;
Pediatr Nephrol; 2024 Jan; 39(1):269-282. PubMed ID: 37365422
[TBL] [Abstract][Full Text] [Related]
11. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
12. Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.
McMahon KR; Rod Rassekh S; Schultz KR; Pinsk M; Blydt-Hansen T; Mammen C; Tsuyuki RT; Devarajan P; Cuvelier GD; Mitchell LG; Baruchel S; Palijan A; Carleton BC; Ross CJ; Zappitelli M;
Can J Kidney Health Dis; 2017; 4():2054358117690338. PubMed ID: 28270931
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
van der Vorst MJDL; Neefjes ECW; Toffoli EC; Oosterling-Jansen JEW; Vergeer MR; Leemans CR; Kooistra MP; Voortman J; Verheul HMW
BMC Cancer; 2019 Nov; 19(1):1066. PubMed ID: 31703649
[TBL] [Abstract][Full Text] [Related]
14. Oliguria and Acute Kidney Injury in Critically Ill Children: Implications for Diagnosis and Outcomes.
Kaddourah A; Basu RK; Goldstein SL; Sutherland SM;
Pediatr Crit Care Med; 2019 Apr; 20(4):332-339. PubMed ID: 30676490
[TBL] [Abstract][Full Text] [Related]
15. Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study.
Gupta S; Glezerman IG; Hirsch JS; Chen KL; Devaraj N; Wells SL; Seitter RH; Kaunfer SA; Jose AM; Rao SP; Ortega JL; Green-Lingren O; Hayden R; Bendapudi PK; Chute DF; Sise ME; Jhaveri KD; Page VD; Abramson MH; Motwani SS; Xu W; Sehgal K; Reynolds KL; Bansal A; Abudayyeh A; Leaf DE
BMJ; 2024 Mar; 384():e077169. PubMed ID: 38538012
[TBL] [Abstract][Full Text] [Related]
16. Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.
James MT; Pannu N; Hemmelgarn BR; Austin PC; Tan Z; McArthur E; Manns BJ; Tonelli M; Wald R; Quinn RR; Ravani P; Garg AX
JAMA; 2017 Nov; 318(18):1787-1797. PubMed ID: 29136443
[TBL] [Abstract][Full Text] [Related]
17. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin.
Motwani SS; McMahon GM; Humphreys BD; Partridge AH; Waikar SS; Curhan GC
J Clin Oncol; 2018 Mar; 36(7):682-688. PubMed ID: 29320311
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Renal Outcomes after Cisplatin Treatment.
Latcha S; Jaimes EA; Patil S; Glezerman IG; Mehta S; Flombaum CD
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1173-1179. PubMed ID: 27073199
[TBL] [Abstract][Full Text] [Related]
20. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.
Zappitelli M; Greenberg JH; Coca SG; Krawczeski CD; Li S; Thiessen-Philbrook HR; Bennett MR; Devarajan P; Parikh CR;
JAMA Pediatr; 2015 Jun; 169(6):583-91. PubMed ID: 25844892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
